No Data
TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10
Insider Buyers At Humacyte Likely Disappointed With 17% Slide
Promising Clinical Outcomes and Imminent FDA Approval Bolster Buy Rating for Humacyte's Bioengineered Vessel
Insider Sale: President of $HUMA (HUMA) Sells 427,459 Shares
Humacyte(HUMA.US) Director Sells US$6.61 Million in Common Stock
Form 144 | Humacyte(HUMA.US) Director Proposes to Sell 3.6 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 18, $HUMACYTE INC C/WTS (TO PUR COM)(HUMAW.US)$、$Humacyte(HUMA.US)$ Director AYABUDGE LLC intends to sell 811.17K shares of its common stock on Nov 18, with a total
Flowerhill : I thought this company’s product is wonderful but I guess they cannot sell. I am stuck